Results 41 to 50 of about 121,794,009 (205)
Toxins, 2020 The aim of the study was to propose a more efficient and safer botulinum toxin type A (BoNT-A) injection method for the masseter by comparing the conventional blind injection and a novel ultrasonography (US)-guided injection technique in a clinical trial.
Hyungkyu Bae +5 more
doaj +1 more source
Neurological Research and Practice, 2019 Background Selective peripheral denervation via botulinum neurotoxin injections into dystonic muscles is the first-line treatment for cervical dystonia.
Thorsten M. Odorfer +4 more
doaj +1 more source
Experience with Relatox® in the combination therapy of arm and hand spasticity after stroke
Неврология, нейропсихиатрия, психосоматика, 2017 Objective: to evaluate the safety, efficacy, and tolerability of the botulinum toxin A Relatox® in arm and hand spasticity after ischemic stroke in routine clinical practice.Patients and methods. The instigation enrolled 7 patients after ischemic stroke (
V. V. Gusev, O. A. Lvova, T. V. Balueva
doaj +1 more source
Long-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from Gastrocnemius Muscle. [PDF]
PLoS ONE, 2015 The aim of the present study was to investigate long term effects of motor denervation by botulinum toxin complex type A (BoNT/A) from Clostridium Botulinum, on the afferent fibers originating from the gastrocnemius muscle of rats.
Guillaume Caron +2 more
doaj +1 more source
Effect of Botulinum Neurotoxin Type A in Induced Benign Prostatic Hyperplasia Male Rats
, 2021 Aim of the study: To explain the mechanism of action and compare the effect of botulinum neurotoxin A with standard treatment (Alfuzosin and dutasteride). Methodology: Five groups each of them composed of 10 rats.
Majid, Ghazi Faisal
core +1 more source
Wound Botulism Caused by Botulinum Neurotoxin Type A in a Chronic Parenteral Drug Abuser
Case Reports in Neurology, 2020 Botulism is an acute paralytic disease caused by botulinum neurotoxin (BoNT)-mediated inhibition of neurosignaling at the neuromuscular junction. BoNTs are produced by gram positive, anaerobic, spore-forming bacteria from the genus Clostridium,most ...
Sohun Awsare +2 more
doaj +1 more source
Supraglottic Botulinum Toxin Injection Improves Symptoms of Laryngeal Sensory Dysfunction
The Laryngoscope, EarlyView.In this retrospective cohort of 80 patients with refractory laryngeal sensory symptoms, supraglottic botulinum toxin type A significantly improved Laryngeal Hypersensitivity Questionnaire, Reflux Symptom Index, and Cough Severity Index scores at a mean of 5.2 weeks, while Voice Handicap Index‐10 scores remained unchanged.
Daniel Novakovic +3 more
wiley +1 more source
ToxinsBotulinum toxin type A is a first-line treatment for post-stroke spasticity, with selective action at nerve endings and minimal effects beyond the injection site.
Alessandro Picelli +4 more
doaj +1 more source
Novel approaches to the treatment of cervical dystonia. The concept of dual navigation control
Неврология, нейропсихиатрия, психосоматика, 2021 Сervical dystonia (CD) is the most common type of focal dystonia (up to 50% of all dystonia cases). Botulinum neurotoxin (BoNT) injections is the treatment choice for CD.
A. P. Kovalenko +2 more
doaj +1 more source
A Targeted Therapeutic Rescues Botulinum Toxin-A Poisoned Neurons [PDF]
, 2008 Botulinum neurotoxin (BoNT), a Category A biothreat agent, is the most potent poison known to mankind. Currently no antidote is available to rescue poisoned synapses.
Radharaman Ray +6 more
core